Presenter: James McCormack BSc (Pharm) Pharm D Mike Allan MD Mike Kolber MD
0:00
In episode 442, James and Mike welcome back Mike Kolber to discuss all the evidence around biosimilars. The issue is exactly the same one we have had for decades with the question around brand name versus generic medications. Tune in and find out the answer. At the conclusion of this activity, participants will be able…
Latest Podcasts
BS Medicine Episode #612: Can fezolinetant improve vasomotor symptoms in menopause?
In episode 612, Tina and James chat with Samantha Moe about the use of a recently approved non-hormonal medication being used for vasomotor symptoms in menopause. We go over the…
BS Medicine Episode #611: Meds for Essential Tremor: Steady solution or shaky science?
In episode 611, Tina and James talk with Samantha Moe about the use of betablockers and other medications for essential tremor. There is some evidence – much of it from…
In the Clinic Episode 52: Statins in the Elderly
In this episode of In the Clinic the team discusses Ticker Endo, a 81 year old who would like a general medication review. To earn an additional 0.25 credits, please…
May 26, 2021
Presenter(s):
James McCormack BSc (Pharm) Pharm D Mike Allan MD Mike Kolber MD
Please provide any additional comments (optional).